PGP and chronic myelogenous leukemia, BCR-ABL1 positive: As a result, we believe it is important to review the pre-clinical approaches involving ABCB1/Pgp expression, activity, and single nucleotide polymorphisms (SNPs) in CML to better understand the role of this protein in the MDR phenotype in the clinical setting.